Understanding Hope and Debunking Its Myths Forge a Valuable Tool for Clinicians Fig 1. Summary of systemic therapy for stage I-III anal SSC recommendations. C, conditional; CRT, chemoradiotherapy; ...
Servier snags FDA approval for Voranigo, the first targeted therapy for a common type of brain tumor
Servier has expanded its IDH drug armamentarium with the FDA approval for an IDH1/2 dual inhibitor. The approval represents the first major treatment advance in low-grade brain cancer in more than two ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback